---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-099576"
form_type: "8-K"
ticker: "ALLR"
cik: "0001860657"
company_name: "Allarity Therapeutics, Inc."
filed_at: "2026-09-14T16:14:05+00:00"
generated_at: "2026-09-14T16:15:12.945856+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Allarity Therapeutics' subsidiary files for SPAC IPO targeting $100M base offering

## Summary
- Allarity Acquisition Corp. filed Form S-1 for IPO of units; base offering $100M, up to $115M with over-allotment.
- ALLR Sponsor LLC, Allarity's wholly-owned sub, is sponsor and expected to hold ~25% of SPAC shares post-offering.
- Jesper Hoiland, Allarity board member and former Novo Nordisk EVP, to serve as Chairman of SPAC.
- SPAC to list on Nasdaq under ALLNU (units), ALLN (Class A), ALLNW (warrants); Maxim Group sole book-runner.
- Offering doesn't change Allarity's working capital runway into summer 2028.

## SEC filing metadata
- accession: 0001213900-26-099576
- form_type: 8-K
- ticker: ALLR
- cik: 0001860657
- company_name: Allarity Therapeutics, Inc.
- filed_at: 2026-09-14T16:14:05+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860657/000121390026099576/0001213900-26-099576-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860657/000121390026099576/ea0305408-8k_allarity.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-099576
- JSON: https://secwatch.observer/filing/0001213900-26-099576.json
- Plain text: https://secwatch.observer/filing/0001213900-26-099576.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.